CD8A and neoplasm: As shown in Fig 4A, at day 25, mice injected with 2 or 5x106 OT-I CD8+ T cells exhibited a significant tumor growth reduction compared with mice receiving no treatment or receiving 1x106 OT-I CD8+ T cells (p< 0.001).